Synchrony Financial (SYF) Expands Into AI Commerce, Is The Stock Cheap?

Intelibly and OpenAI Deals Put Synchrony Financial’s Digital Ambitions in Focus

Synchrony Financial (SYF) is moving deeper into embedded finance by tying its CareCredit offering into Intelibly Inc.’s dental booking platform and by aligning its credit and rewards programs with AI shopping tools through an enterprise collaboration with OpenAI.

Recent trading has been choppy for Synchrony Financial, with the share price down 6.55% over the past 30 days and 13.83% year to date. At the same time, the 3 year total shareholder return of about 155% and 5 year total shareholder return of roughly 64% point to strong longer run momentum that contrasts with the more cautious tone priced in this year, as investors weigh new digital partnerships against changing risk perceptions.

Scan other AI-focused financial players that are moving early on embedded experiences with our curated list of 37 profitable AI stocks that aren't just burning cash, which pairs real earnings with exposure to this shift in digital commerce.

Synchrony Financial now pairs a softer share price with fresh AI and healthcare hooks into customer spending. Does that reset leave enough upside to justify the risk investors are taking today?

Most Popular Narrative: 18% Undervalued

Synchrony Financial closed at $72.94 while the most followed narrative pegs fair value at $89.22. This frames the current discount as a bet on how well its credit model and digital push hold up against consumer and regulatory pressure.

The company's proactive investment in advanced data analytics, AI, and end-to-end digital platforms, including deeper digital integration of new cards with PayPal and Walmart, enhances risk management and operational efficiency, thereby supporting improved net interest margins and lower charge-offs as these technologies mature.

See why 35 investors see Synchrony Financial as 18% undervalued.

Result: Fair Value of $89.22 (UNDERVALUED)

Still, the story can break if Synchrony Financial loses a major retail partner, or if higher regulatory costs squeeze returns from all that AI investment.

Find out about the key risks to this Synchrony Financial narrative.

Next Steps

Mixed views like these are exactly where careful investors can gain an edge. Move quickly, stress test Synchrony Financial against both sides of the argument, then weigh the 4 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Synchrony Financial?

Do not stop your research with Synchrony Financial. Use fresh screeners to quickly surface other stocks that match the kind of risk and return profile you actually want.

• Target resilient balance sheets by scanning a curated list of solid balance sheet and fundamentals (24 results) that filters for companies with stronger financial foundations.
• Hunt for potential mispricings through the 32 high quality undervalued stocks and see which businesses the numbers suggest could be trading below their fundamentals.
• Build a watchlist of future contenders using the 16 high quality undiscovered gems that highlights quality companies still flying under most investors' radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com